Briefing: The Research on Workplace Accommodations for Migraine Sufferers

Location: 
Russell Senate Office Building, Room 188
Address: 
2 Constitution Ave NE
Washington, DC 20002
United States
Event Date: 
Wednesday, October 3, 2018
12:00 p.m. - 1:00 p.m.

Experts representing the patient and disability communities, employers, and researchers, will share insights on advances in research and treatment, and workplace accommodations for migraine sufferers at a congressional briefing hosted by Research!America on Wednesday, October 3. Confirmed speakers include Amy Miller, Ph.D., president and CEO, Society for Women's Health Research; Stacey Worthy, JD, counsel, Aimed Alliance; and Eileen Brewer, migraine patient advocate and Director of Communication and Education, Clusterbusters. Kevin Lenaburg, executive director, Coalition for Headache and Migraine Patients (CHAMP), will moderate the panel. The briefing will be held in the Senate Russell Office Building, Room 188, noon to 1 p.m. ET.

According to the National Institutes of Health, the pain of migraine is often described as an intense pulsing or throbbing pain in one area of the head. Symptoms include nausea, vomiting or sensitivity to both light and sound. Currently, there is no cure for migraine. With few treatments available, sufferers say they cope with debilitating pain that makes everyday life, including work, nearly impossible.

Employees who suffer from migraines and other chronic severe headaches tend to report lower job performance and may be absent more often than other workers, according to the Integrated Benefits Institute. Nearly half (45%) of migraine sufferers and about one-in-five non-sufferers say they know someone with the condition who has left the workforce or reduced their work hours due to the progression of their disease, according to a survey commissioned by Research!America. Employers should make reasonable workplace accommodations for migraine sufferers, according to 76% of sufferers and 58% of non-sufferers who responded to the survey. 

This program is supported in part by Amgen. Please RSVP by filling out this form

Media Contacts

Anna Briseño
Senior Director of Communications 
571-482-2737

The capabilities are enormous, a little bit of research can pay off quite a bit in the long run.
Paul D’ Addario, retinitis pigmentosa patient